Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 | Avg patent value: 5.18 M | |||
2 | Avg patent value: 1.18 M | |||
3 | Avg patent value: 1.18 M | |||
4 | Avg patent value: 340,000 | |||
5 | Avg patent value: 0 |
Top 5 Key Players companies in Dengue vaccine
by Highest Patent Value in the United States in 2022
The Dengue vaccine top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Dengue vaccine Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Dengue vaccine is a vaccine to prevent dengue fever in humans. The World Health Organization (WHO) only recommends the vaccine in those who have previously had dengue fever or populations in which most people have been previously infected. The value of this vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected.
Page generation time:
Jul 11 2025